Triple-negative breast cancer accounts for approximately 15% of all breast cancer cases. Patients with this subtype typically have poorer outcomes compared to other breast cancers, suggesting the need for improved treatments. ...
Feb 9, 2023
0
174
In the five years since the FDA's initial approval of chimeric antigen receptor (CAR) T cell therapy, Penn Medicine has gleaned 20 additional approvals related to drugs and techniques to treat or detect cancer.
May 29, 2023
0
33
Exercise decreases the risk of cancer and reduces side effects of cancer treatments. In addition, it improves patients' quality of life and the prognosis of cancer patients. This is according to two new Finnish studies.
May 2, 2023
0
401
Researchers at the University of Colorado Anschutz Medical Campus have discovered a drug combination that may offer a better prognosis for children diagnosed with MYC amplified Medulloblastoma, an often deadly form of brain ...
Jan 16, 2023
0
29
Error-correcting mechanisms are very important for cells, because with all the cellular activity constantly going on, malfunctions arise all the time. But when it comes to killing cancer cells, it is in the cells' best interest ...
Jan 27, 2023
0
95
Dogs are humans' best friends and it is always distressing for dog owners when their beloved pets contract terminal illnesses. Canine cancer is the leading cause of death in dogs and when they are diagnosed with late-stage ...
Jan 30, 2023
0
17
The myth that people with dark skin are immune to melanoma, a type of skin cancer, has persisted for many years. It's a dangerous misconception that has caused some people not to be diligent about protecting themselves against ...
May 12, 2023
0
3
A new AI (artificial intelligence) tool may make it possible to spare breast cancer patients unnecessary chemotherapy treatments by using a more precise method of predicting their outcomes, reports a new Northwestern Medicine ...
Nov 27, 2023
0
68
Immunotherapy is a highly effective treatment for patients whose cancers harbor mismatch repair deficiency, and a new study identifies more cancer patients who could benefit from this form of therapy. Investigators from Brigham ...
Dec 29, 2023
0
46
Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation ...
Apr 17, 2023
0
2
